Literature DB >> 7721852

The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans.

M Z Kounnas1, D A Chappell, H Wong, W S Argraves, D K Strickland.   

Abstract

Hepatic lipase (HL) and lipoprotein lipase (LpL) are structurally related lipolytic enzymes that have distinct functions in lipoprotein catabolism. In addition to its lipolytic activity, LpL binds to very low density lipoproteins and promotes their interaction with the low density lipoprotein receptor-related protein (LRP) (Chappell, D. A., Fry, G. L., Waknitz, M. A., Muhonen, L. E., Pladet M. W., Iverius, P. H., and Strickland, D. K. (1993) J. Biol. Chem. 268, 14168-14175). In vitro binding assays revealed that HL also binds to purified LRP with a KD of 52 nM. Its binding to LRP is inhibited by the 39-kDa receptor-associated protein (RAP), a known LRP antagonist, and by heparin. 125I-Labeled HL is rapidly internalized and degraded by HepG2 cell lines, and approximately 70% of the cellular internalization and degradation is blocked by either exogenously added RAP or anti-LRP IgG. Mouse fibroblasts that lack LRP display a greatly diminished capacity to internalize and degrade HL when compared to control fibroblasts. These data indicate that LRP-mediated cellular uptake of HL accounts for a substantial portion of the internalization of this molecule. Proteoglycans have been shown to participate in the clearance of LpL, and consequently a role for proteoglycans in HL clearance pathway was also investigated. Chinese hamster ovary cell lines that are deficient in proteoglycan biosynthesis were unable to internalize or degrade 125I-HL despite the fact that these cells express LRP. Thus, the initial binding of HL to cell surface proteoglycans is an obligatory step for the delivery of the enzyme to LRP for endocytosis. A small, but significant, amount of 125I-HL was internalized in LRP deficient cells indicating that an LRP-independent pathway for HL internalization does exist. This pathway could involve cell surface proteoglycans, the LDL receptor, or some other unidentified surface protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721852     DOI: 10.1074/jbc.270.16.9307

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Secretion of hepatic lipase by perfused liver and isolated hepatocytes.

Authors:  X Galan; M Q Robert; M Llobera; I Ramírez
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

Review 3.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 4.  Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease.

Authors:  Maria-Paz Marzolo; Guojun Bu
Journal:  Semin Cell Dev Biol       Date:  2008-10-17       Impact factor: 7.727

5.  Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.

Authors:  S Tumova; B A Hatch; D J Law; K J Bame
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

6.  Very low density lipoproteins stimulate surfactant lipid synthesis in vitro.

Authors:  R K Mallampalli; R G Salome; S L Bowen; D A Chappell
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

7.  Identification of a heparin-releasable hepatic lipase binding protein from rat liver.

Authors:  B Breedveld; K Schoonderwoerd; H Jansen
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

8.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Authors:  E Tahvanainen; M Syvanne; M H Frick; S Murtomaki-Repo; M Antikainen; Y A Kesaniemi; H Kauma; A Pasternak; M R Taskinen; C Ehnholm
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

9.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

10.  LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue.

Authors:  Olivier Masson; Carine Chavey; Cédric Dray; Aline Meulle; Danielle Daviaud; Didier Quilliot; Catherine Muller; Philippe Valet; Emmanuelle Liaudet-Coopman
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.